Indee Labs is a biotechnology startup backed by SOSV, Y Combinator, Social Capital and Founders Fund. The team at Indee Labs develops and markets Hydropore for more effective engineered cell therapies. Indee Lab’s non-viral delivery platform, Hydropore, is a robust solution that overcomes the limitations and costs of electroporation, viral transduction, and other non-viral transfection methods. Hydropore is being developed in collaboration with 3 of the top 10 pharmaceutical companies, various biotechs and leading research institutions including UC San Francisco, Stanford, Medical University of South Carolina, the National Cancer Institute and the National Institute of Allergy and Infectious Disease among others.